Molecular Monitoring of Chronic Myeloid Leukemia

Slides:



Advertisements
Similar presentations
Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification.
Advertisements

Nine Novel Germline Gene Variants in the RET Proto-Oncogene Identified in Twelve Unrelated Cases Syed A. Ahmed, Karen Snow-Bailey, W. Edward Highsmith,
A Multiplex qPCR Gene Dosage Assay for Rapid Genotyping and Large-Scale Population Screening for Deletional α-Thalassemia Wanjun Zhou, Ge Wang, Xuefeng.
CC Chemokine Receptor 5 and CXC Chemokine Receptor 6 Expression by Lung CD8+ Cells Correlates with Chronic Obstructive Pulmonary Disease Severity Christine.
Development of a Novel One-Tube Isothermal Reverse Transcription Thermophilic Helicase-Dependent Amplification Platform for Rapid RNA Detection James Goldmeyer,
Telomerase Activity and Expression of Telomerase RNA Component and Telomerase Catalytic Subunit Gene in Cervical Cancer Kenji Nakano, Elizabeth Watney,
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Neal I. Lindeman, Philip T. Cagle, Mary Beth.
CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma Carol D. Jones, Katherine H. Darnell, Roger A.
Quantification of Parvovirus B19 DNA Using COBAS AmpliPrep Automated Sample Preparation and LightCycler Real-Time PCR Stefan Schorling, Gunnar Schalasta,
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma  Qiushi Wang, Xin Yang, Yong He, Qiang Ma, Li Lin,
Genotyping of Chimerical BCR-ABL1 RNA in Chronic Myeloid Leukemia by Integrated DNA Chip  Jong-Hun Kang, Hyun-Gyung Goh, Sang-Ho Chae, Sung-Yong Kim,
Monitoring and Prevention of Relapse after Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies  Ulrike Bacher, Julie-An Talano, Michael.
Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post–Allogeneic Stem Cell Transplantation Chronic.
Laboratory Guidelines for Detection, Interpretation, and Reporting of Maternal Cell Contamination in Prenatal Analyses  Narasimhan Nagan, Nicole E. Faulkner,
The Spectrum of CFTR Variants in Nonwhite Cystic Fibrosis Patients
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors  Neal I. Lindeman, Philip T. Cagle, Mary.
Genome-editing Technologies for Gene and Cell Therapy
Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic.
Β-Glucuronidase Is an Optimal Normalization Control Gene for Molecular Monitoring of Chronic Myelogenous Leukemia  Joong Won Lee, Qiaofang Chen, Daniel.
Comprehensive Analysis of CBFβ-MYH11 Fusion Transcripts in Acute Myeloid Leukemia by RT-PCR Analysis  ShriHari S. Kadkol, Annette Bruno, Carol Dodge,
Development and Validation of a Preanalytic Procedure for Performing the cobas HPV Test in SurePath Preservative Fluid  Mark D. Krevolin, David Hardy,
Molecular Monitoring of Residual Disease in Chronic Myeloid Leukemia by Genomic DNA Compared with Conventional mRNA Analysis  Elia Mattarucchi, Orietta.
A DNA Real-Time Quantitative PCR Method Suitable for Routine Monitoring of Low Levels of Minimal Residual Disease in Chronic Myeloid Leukemia  Paul A.
Adrian G. Selim, Andrew S. Moore  The Journal of Molecular Diagnostics 
Joanna Wang, Chetan Bettegowda  The Journal of Molecular Diagnostics 
Comparison of High-Resolution Melting Analysis, TaqMan Allelic Discrimination Assay, and Sanger Sequencing for Clopidogrel Efficacy Genotyping in Routine.
Lauren M. Stanoszek, Erin L. Crawford, Thomas M. Blomquist, Jessica A
Cornelis J. J. Huijsmans, Jeroen Poodt, Paul H. M. Savelkoul, Mirjam H
Characterization of the Different BCR-ABL Transcripts with a Single Multiplex RT-PCR  Jacques Chasseriau, Jérôme Rivet, Frédéric Bilan, Jean-Claude Chomel,
Jeung-Yeal Ahn, Katie Seo, Olga Weinberg, Scott D. Boyd, Daniel A
Single Monochrome Real-Time RT-PCR Assay for Identification, Quantification, and Breakpoint Cluster Region Determination of t(9;22) Transcripts  Marina.
A Lean Laboratory The Journal of Molecular Diagnostics
Molecular Monitoring of Residual Disease in Chronic Myeloid Leukemia by Genomic DNA Compared with Conventional mRNA Analysis  Elia Mattarucchi, Orietta.
Influenza A Subtyping The Journal of Molecular Diagnostics
ALK Status Testing in Non–Small Cell Lung Carcinoma
Gene Scanning of an Internalin B Gene Fragment Using High-Resolution Melting Curve Analysis as a Tool for Rapid Typing of Listeria monocytogenes  Ariane.
Patrick R. Murray  The Journal of Molecular Diagnostics 
Chronic Myeloid Leukemia
William L. Gerald, M.D., Ph.D, 1954–2008
The Human Androgen Receptor X-Chromosome Inactivation Assay for Clonality Diagnostics of Natural Killer Cell Proliferations  Michaël Boudewijns, Jacques.
Development of an NPM1/MLF1 D-FISH Probe Set for the Detection of t(3;5)(q25;q35) Identified in Patients with Acute Myeloid Leukemia  Umut Aypar, Ryan.
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia  Claudia Brunetti, Luisa Anelli, Antonella.
Christine Formisano-Tréziny, Marina de San Feliciano, Jean Gabert 
BRAF Mutation Testing in Solid Tumors
Mutational Analysis of BRAF Inhibitor–Associated Squamoproliferative Lesions  Britt Clynick, Tania Tabone, Kathryn Fuller, Wendy Erber, Katie Meehan, Michael.
The Molecular Pathology of Primary Immunodeficiencies
Modified Real-Time PCR for Detecting, Differentiating, and Quantifying Ureaplasma urealyticum and Ureaplasma parvum  Ellen Vancutsem, Oriane Soetens,
BCR-ABL1 RT-qPCR for Monitoring the Molecular Response to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia  Richard D. Press, Suzanne Kamel-Reid,
Detection and Discrimination between Deletional and Non-Deletional Prader-Willi and Angelman Syndromes by Methylation-Specific PCR and Quantitative Melting.
Molecular Monitoring of Chronic Myelogenous Leukemia
A Simple Method to Confirm and Size Deletion, Duplication, and Insertion Mutations Detected by Sequence Analysis  Lawrence N. Hjelm, Ephrem L.H. Chin,
Genome-editing Technologies for Gene and Cell Therapy
Design and Evaluation of a Real-Time PCR Assay for Quantification of JAK2 V617F and Wild-Type JAK2 Transcript Levels in the Clinical Laboratory  Jason.
Evaluating the Effect of Unclassified Variants Identified in MMR Genes Using Phenotypic Features, Bioinformatics Prediction, and RNA Assays  Lucia Pérez-Cabornero,
Quantification of Circulating miRNAs in Plasma
Retrospective Comparison of Nucleic Acid Sequence–Based Amplification, Real-Time PCR, and Galactomannan Test for Diagnosis of Invasive Aspergillosis 
Jianbo Song, Danielle Mercer, Xiaofeng Hu, Henry Liu, Marilyn M. Li 
Ayalew Tefferi, Pierre Noel, Curtis A. Hanson 
Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic.
Detection and Quantification of BCR-ABL1 Fusion Transcripts by Droplet Digital PCR  Lawrence J. Jennings, David George, Juliann Czech, Min Yu, Loren Joseph 
Karen Snow-Bailey, Ph.D., 1961–2006
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
Tong Zhang, Sylvie Grenier, Bevoline Nwachukwu, Cuihong Wei, Jeffrey H
Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay  Thomas.
Angiotensin I-Converting Enzyme
Monique A. Johnson, Marvin J. Yoshitomi, C. Sue Richards 
Attacking Cancer at Its Root
Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA  Justin T. Brown, Ion J. Beldorth,
The History and Impact of Molecular Coding Changes on Coverage and Reimbursement of Molecular Diagnostic Tests  Susan J. Hsiao, Mahesh M. Mansukhani,
Presentation transcript:

Molecular Monitoring of Chronic Myeloid Leukemia ChaoJie Zhen, Y. Lynn Wang  The Journal of Molecular Diagnostics  Volume 15, Issue 5, Pages 556-564 (September 2013) DOI: 10.1016/j.jmoldx.2013.05.010 Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 Diagram of how BCR-ABL1 transcript levels change with tyrosine kinase inhibitor treatment over time. Responding patients experience a continuum of therapeutic milestones. CHR, complete hematological response; CMR, CMR representing 0.032%IS; Ctrl, control; MMR, MMR representing 0.1%IS. Asterisk, the 100% standardized baseline defined by the mean transcript level in a pool of 30 diagnostic CML specimens used in the IRIS trial (see Reference Materials). The Journal of Molecular Diagnostics 2013 15, 556-564DOI: (10.1016/j.jmoldx.2013.05.010) Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 2 The principal steps of the RT-qPCR procedure. Most laboratories isolate total white blood cells by performing a simple step of red cell lysis (single asterisk). qPCR of BCR-ABL1 and the control gene are normally performed in parallel in the same run, and duplicate analysis of the standard curves, references, and patient materials is normally required for accurate quantification (double asterisks). The Journal of Molecular Diagnostics 2013 15, 556-564DOI: (10.1016/j.jmoldx.2013.05.010) Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions